KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationInvestment in Debt & EquityLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Inovio Pharmaceuticals (INO) Receivables - Net (2016 - 2025)

Inovio Pharmaceuticals' Receivables - Net history spans 16 years, with the latest figure at $978590.0 for Q3 2025.

  • For Q3 2025, Receivables - Net fell 47.46% year-over-year to $978590.0; the TTM value through Sep 2025 reached $978590.0, down 47.46%, while the annual FY2024 figure was $1.2 million, 50.15% down from the prior year.
  • Receivables - Net for Q3 2025 was $978590.0 at Inovio Pharmaceuticals, up from $840312.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $13.1 million in Q2 2021 and bottomed at $73304.0 in Q1 2023.
  • The 5-year median for Receivables - Net is $2.5 million (2022), against an average of $4.0 million.
  • The largest annual shift saw Receivables - Net tumbled 98.17% in 2023 before it soared 3380.14% in 2024.
  • A 5-year view of Receivables - Net shows it stood at $5.5 million in 2021, then soared by 81.09% to $9.9 million in 2022, then tumbled by 75.7% to $2.4 million in 2023, then crashed by 50.15% to $1.2 million in 2024, then dropped by 18.39% to $978590.0 in 2025.
  • Per Business Quant, the three most recent readings for INO's Receivables - Net are $978590.0 (Q3 2025), $840312.0 (Q2 2025), and $1.3 million (Q1 2025).